Abstract
Objectives: It is possible for baseline imbalances to occur between treatment groups for one or more variables in a randomized controlled trial, although the identification and detection of baseline imbalances remain controversial. If trials with baseline imbalances are combined in a meta-analysis, then this may result in misleading conclusions. Study Design and Setting: The identification and consequences of baseline imbalances in meta-analyses are discussed. Metaregression using mean baseline scores as a covariate is proposed as a potential method for adjusting baseline imbalances within meta-analysis. We will use a recent systematic review looking at the effect of calcium supplements on weight as an illustrative case study. Results: Meta-analysis conducted using the mean final values of the treatment groups as the outcome resulted in an apparent, statistically significant, treatment effect. However, using a meta-analysis of baseline values, this was shown to be due to the baseline imbalance between treatment groups, rather than as a result of any intervention received by the participants. Applying the method of metaregression demonstrated that there was in fact a smaller, statistically insignificant effect between treatment groups. Conclusion: The meta-analyst should always consider the possibility of baseline imbalances and adjustments should be made wherever possible. © 2007 Elsevier Inc. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 1229-1233 |
Number of pages | 4 |
Journal | Journal of Clinical Epidemiology |
Volume | 60 |
Issue number | 12 |
DOIs | |
Publication status | Published - Dec 2007 |
Keywords
- Baseline differences
- Baseline imbalances
- Clinical Trials
- Meta-analysis
- Randomization
- Systematic reviews